[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Emerging Clinical Chemistry and Immunodiagnostic Markets: Innovative Technologies and Strategic Profiles of Leading Suppliers

November 2021 | | ID: 2120326F472EN
Venture Planning Group

US$ 4,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and others.

The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
CURRENT AND EMERGING TECHNOLOGIES

MONOCLONAL AND POLYCLONAL ANTIBODIES

IMMUNOASSAYS

a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

IT AND AUTOMATION

Dry Chemistry
Biosensors
Robotics

MOLECULAR DIAGNOSTICS

a. Detection Technologies
  1. Radioactive Methods
  2. Non-Isotopic Methods
b. Instrumentation Review
  Abbott LCX
  BeckmanCoulter/Biomek FX
  Becton Dickinson
  Bio-Rad Gene Scope
  Roche Cobas Amplicor
  Tecan LS Series
c. Biochips Genosensor, Microarrays, Labs-on-the-Chips Chemometrics

COMPETITIVE PROFILES

Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio Grifols
Instrumentation
Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako


More Publications